Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 25 studies | 50% ± 16% | |
monocyte | 17 studies | 34% ± 13% | |
conventional dendritic cell | 17 studies | 30% ± 13% | |
macrophage | 13 studies | 32% ± 14% | |
non-classical monocyte | 13 studies | 24% ± 9% | |
dendritic cell | 10 studies | 33% ± 15% | |
fibroblast | 9 studies | 23% ± 6% | |
myeloid cell | 7 studies | 37% ± 14% | |
alveolar macrophage | 6 studies | 42% ± 13% | |
neutrophil | 5 studies | 45% ± 21% | |
epithelial cell | 5 studies | 28% ± 10% | |
mononuclear phagocyte | 3 studies | 31% ± 7% | |
intermediate monocyte | 3 studies | 49% ± 17% | |
intestinal crypt stem cell | 3 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 98% | 1607.41 | 951 / 966 | 99% | 124.31 | 520 / 527 |
pancreas | 100% | 1199.01 | 328 / 328 | 94% | 122.83 | 168 / 178 |
bladder | 100% | 2491.24 | 21 / 21 | 93% | 107.69 | 470 / 504 |
kidney | 100% | 1327.71 | 89 / 89 | 93% | 47.65 | 836 / 901 |
lung | 100% | 2781.18 | 578 / 578 | 90% | 65.21 | 1042 / 1155 |
breast | 100% | 1589.63 | 459 / 459 | 89% | 46.00 | 997 / 1118 |
esophagus | 94% | 2080.32 | 1358 / 1445 | 94% | 90.50 | 172 / 183 |
uterus | 98% | 1112.82 | 166 / 170 | 89% | 67.99 | 407 / 459 |
stomach | 87% | 776.85 | 312 / 359 | 97% | 125.81 | 277 / 286 |
thymus | 94% | 748.28 | 613 / 653 | 47% | 12.71 | 286 / 605 |
ovary | 57% | 345.76 | 102 / 180 | 64% | 24.62 | 274 / 430 |
skin | 72% | 1721.90 | 1309 / 1809 | 41% | 20.07 | 192 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 136.62 | 1 / 1 |
adipose | 100% | 1673.89 | 1202 / 1204 | 0% | 0 | 0 / 0 |
spleen | 98% | 2985.74 | 235 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 1542.04 | 837 / 861 | 0% | 0 | 0 / 0 |
prostate | 81% | 549.77 | 198 / 245 | 10% | 1.84 | 48 / 502 |
tonsil | 0% | 0 | 0 / 0 | 89% | 52.44 | 40 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 35.97 | 25 / 29 |
peripheral blood | 82% | 22409.39 | 766 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 67% | 600.60 | 893 / 1335 | 0% | 0 | 0 / 0 |
muscle | 56% | 292.16 | 447 / 803 | 0% | 0 | 0 / 0 |
liver | 21% | 109.03 | 47 / 226 | 17% | 8.17 | 71 / 406 |
adrenal gland | 31% | 154.90 | 81 / 258 | 6% | 1.53 | 13 / 230 |
eye | 0% | 0 | 0 / 0 | 29% | 6.76 | 23 / 80 |
brain | 4% | 20.69 | 114 / 2642 | 14% | 3.50 | 100 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009395 | Biological process | phospholipid catabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005764 | Cellular component | lysosome |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0004620 | Molecular function | phospholipase activity |
Gene name | PLBD1 |
Protein name | Phospholipase B-like (EC 3.1.1.-) Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C] Phospholipase B domain containing 1 |
Synonyms | |
Description | FUNCTION: In view of the small size of the putative binding pocket, it has been proposed that it may act as an amidase or a peptidase (By similarity). Exhibits a weak phospholipase activity, acting on various phospholipids, including phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine and lysophospholipids. . FUNCTION: Putative phospholipase. . |
Accessions | F5H053 ENST00000541618.1 ENST00000240617.10 Q6P4A8 F5GYQ3 ENST00000540572.1 |